The European Society
of Human Genetics

Calls for collaboration

Calls for collaboration

Call for Clinical Paediatric Experts

conect4children c4c-S (conect4children.eu) and conect4children is a pan-European clinical trial network is a pan-European clinical trial network that dedicated to facilitating the development of new drugs and therapies for the entire pediatric population.

c4c is seeking clinical paediatric experts to join its European initiative, which focuses on supporting the development of new therapies for the paediatric population. Experts will provide strategic feasibility advice to pharmaceutical companies and academic sponsors.

One of the key goals of c4c is to provide expert advice to improve child health and paediatric medicine development. Groups of experts (methodological, clinical, and parents/patients) were set up to provide advice service to requests from industry and academic stakeholders in conducting feasible, innovative and scientifically sound paediatric clinical trials.

Currently, c4c is expanding its network of Experts and is looking clinical pediatric experts interested in joining our Clinical and/or Methodology Expert Groups. We invite those who are interested in contributing their knowledge and experience to our advisory services.

We aim for diversity, including representatives from different career levels, genders, European regions and from a wide range of clinical subspecialties. Even if you are a clinician specialized in a very specific patient population, with limited research experience, we encourage you to apply.

This is a pioneering opportunity to be part of a group that provides scientific feasibility guidance whilst ensuring the needs of babies, children, young people, and their families are met. If studies are better designed, then we will have better outcomes!

More information: Methodology Expert Groups & Clinical Expert Groups
If you are interested, please complete the application form and send a CV and motivation letter to: c4c.spoc(at)conect4children.eu. The deadline for applications is 21 February 2025.

CALL FOR RESEARCH PROJECT PROPOSALS 2025 EDITION

true

The Associazione Mia Neri Foundation Onlus (MNF) (www.mianerifoundation.it) will fund two basic research projects in the field of childhood brain tumors with a 100,000 grant for each project over a two-year period. Priority will be given to projects submitted by young investigators. The proposals will be reviewed by experts in the field and the winners will be selected by the Scientific Committee of the MNF, based on the reviewers’ evaluations.

Project proposals should be submitted to the MNF at mianerifoundation(at)gmail.com no later than June 30th 2025 in the following format:

  1. Proponent’s name, short cv (showing age) and contact details
  2. Project  title and abstract (half page)
  3. Background, including preliminary results
  4. Hypotheses and specific aims
  5. Research plan, including expected results
  6. Name of external collaborators, if any          
  7. Budget

Sections 3-5 should not exceed 5 pages, excluding figures and references. Font no smaller than Times New Roman 12, margins at least 2 cm each.

The proposals should be accompanied by a letter of acceptance of the Institution where the research project will be carried out.

The winners will be announced no later than October 31st 2025

Funds will be made available in two installments of 50,000 € each after clearance of the project by the local Ethics Committee, if required.

Inquiries on this call should be addressed to Giovanni Neri, president of the Associazione Mia Neri Foundation at mianerifoundation(at)gmail.com

CALL FOR ORIGINAL RESEARCH PROJECT PROPOSALS BY YOUNG INVESTIGATORS

true

The Associazione Mia Neri Foundation Onlus (MNF) (www.mianerifoundation.it) will fund two basic research projects (one for all applicants and one reserved to Italian applicants) in the field of childhood brain tumors with a 50,000 grant. Proponents’ age should not exceed 30 years old. The proposal should be accompanied by a statement explaining how the project is driven by an innovative hypothesis different from the main line of research of the hosting lab and what are the expected benefits if such hypothesis is confirmed. The proposals will be reviewed by experts in the field and the winners will be selected by the Scientific Committee of the MNF, based on the reviewers’ evaluations.

Project proposals should be submitted to the MNF at mianerifoundation(at)gmail.com no later than June 30th 2025 in the following format:

  1. Proponent’s name, short cv (showing age) and contact details
  2. Project  title and abstract (half page)
  3. Background, including preliminary results
  4. Hypotheses and specific aims
  5. Research plan, including expected results
  6. Name of external collaborators, if any          
  7. Budget

Sections 3-5 should not exceed 5 pages, excluding figures and references. Font no smaller than Times New Roman 12, margins at least 2 cm each.

The proposals should be accompanied by a letter of acceptance of the Institution where the research project will be carried out.

The winners will be announced no later than October 31st 2025

Funds will be made available in a single installment of 50,000 € after clearance of the project by the local Ethics Committee, if required.

Inquiries on this call should be addressed to Giovanni Neri, president of the Associazione Mia Neri Foundation at mianerifoundation(at)gmail.com

Assessment of Current and Future Approaches to Address Variants of Uncertain Significance in Hearing and Ocular Genomics Domains

We have designed a questionnaire that aims to explore the practices and experiences of professionals in the hearing loss and ocular genetics domains who are actively incorporating variant-level functional data into workflows. By focusing on these areas, we seek to gather diverse perspectives on variants of uncertain significance (VUS) and better understand how current and future functional data will be integrated into clinical practice.

We aim to address key topics, including:

  • The impact of VUS in routine workflows
  • The practical applications and challenges of using functional evidence criteria in variant classification
  • The level of confidence in applying functional evidence criteria
  • Expectations for the type of information included when aggregating variant classification evidence at a single source like ClinVar
  • Perspectives for future inclusion of high-throughput approaches, such as multiplexed assays of variant effect (MAVEs), into resources like ClinVar

Our goal is to enhance understanding of the current awareness and application of functional data for interpreting VUS within these two clinical domains. We join international efforts to address the challenges posed by VUS. Functional data have conventionally been generated on a variant-by-variant basis using cell or animal models. However, scalable functional assays like MAVEs offer the potential to accelerate VUS reclassification, providing more certainty about whether variants are pathogenic or benign. This study seeks to capture current and future perspectives on these developments from active members of the hearing loss and ocular genetics communities.

This questionnaire is anticipated to take 15-20 minutes.

The questionnaire can be accessed here: https://redcap.link/VUS_survey_hearing_and_ocular_genomics

We appreciate your participation and willingness to contribute to this important work. Questions can be directed to Dr. Barbara Vona (barbara.vona(at)med.uni-goettingen.de).

Survey on need for registration of Bioinformaticians as Clinical Laboratory Geneticists (focus on Bioinformatics)

The EBMG – branch of ErCLGs – offers since 10 years the possibility to register as Clinical Laboratory Geneticists as

  • European registered Clinical Laboratory Geneticists (general)
  • European registered Clinical Laboratory Geneticists (focus on Clinical Genetics)
  • European registered Clinical Laboratory Geneticists (focus on Molecular Genetics)
  • European registered Clinical Laboratory Geneticists (focus on Biochemical Genetics)
  • European registered Clinical Laboratory Geneticists (focus on Tumorgenetics)

To find out if there is a need for opening a possibility for registration as European registered Clinical Laboratory Geneticists (focus on Bioinformatics) we start this survey!

In case, you are interested in registration as European registered Clinical Laboratory Geneticists (focus on Bioinformatics) under the conditions mentioned below, send a mail to Thomas.Liehr(at)med.uni-jena.de until 31.03.2025 just stating that you would like to use that way to show your competence.

Details on what we offer are provided on https://www.ebmg.eu/587.0.html. Before you ask any questions to Thomas Liehr make sure you have read and understood that page.

The requirements for application:

  • Hold an M.Sc. and/or PhD qualification;
  • Work under a contract for at least 8 years in Human Genetics, actively undertake laboratory diagnostics and sign / be responsible for a minimum of 200 reports per year;
  • Applicants working for more than 10 years should have signed reports during at least 3 of the last 5 years;
  • Applicant need to follow during their work the "code of professional practice for clinical laboratory geneticists in Europe" - this has to be confirmed by your witnesses during step 2 of application;
  • Ongoing education: at least 35 hours per year - to be recorded for the last 2 years before application (15h internal and 20h external ones);
  • Fee has to be paid – as we have a 2 step submission system inviting for payment after an initial check for eligability, paid fees are not reimbursable.
  • At least 1 specialized course in Human Genetic diagnostics with a certificate proofing successful passing of a final test or daily tests and a duration of the course of at least 3 days (link for courses, which can be used);
  • At least 1 specialized course in Human Genetic diagnostics with a certificate proofing participation and a duration of the course of at least 3 days (link for courses, which can be used);
  • Examination by the EBMG Professional Branch Board for Clinical Laboratory Geneticists - date and place to be announced by January 15th of the year following the actual application round:
    1. written exam to test theoretical knowledge.
    2. individual oral discussion checking experience in diagnostics.
  • Not requested or evaluated are scientific records, like publication lists.

 

canSERV - Invitation to join the European Network for Personalized Oncology and its European Molecular Tumor Board Network

A european-wide initiative by the EU cluster project canSERV

We would like to invite anyone involved in a Molecular Tumor Board (MTB) – e.g., physicians, scientists, patient representatives, ethicists – to join the European Network for Personalised Oncology (ENPO) and its European Molecular Tumor Board Network (EMTBN), both being established through the EU cluster project canSERV (visit canSERV About). The European Network for Personalised Oncology (ENPO) aims to provide state-of-the-art guidance and support to accelerate the implementation of personalised oncology. Through canSERV, the ENPO will establish the European Molecular Tumor Board Network (EMTBN), which aims to guide the establishment of MTB Standard Operating Procedures (consensus standards) and the set-up of a public registry of MTB recommendation outcomes. The ENPO and EMTBN will not be limited to the canSERV consortium partners but open to the wider community to be as inclusive and engaging as possible. Although participation in the networks is on a voluntary basis, some specific activities can be considered for cost reimbursement for those who will actively contribute.

More information

canSERV - Call for Service Provision on ”Advancing Personalised Oncology"

The canSERV Consortium announces its first Challenge-Call on

“Advancing Personalised Oncology”.

Cancer Researchers in, and outside the EU are invited to apply for free access to cutting-edge transnational services with an indicative overall budget of EUR 500,000. The aim of this call is to accelerate knowledge gain in personalised oncology with specific emphasis on multi-level data-based treatment guidance linked to Molecular Tumour Boards1.

The projects supported under this call will support the advancement and implementation of personalized medicine strategies for all cancer patients in Europe, contributing to the overarching goals of the Cancer Mission Board.

More information

IGPrare Project - Partnership between Aix-Marseille University and EURODIS

This research project, elaborated in collaboration with Eurordis (https://www.eurordis.org/), aims to study the genetic information disclosure to a patient's family in case of a diagnosis of rare genetic disease, and to propose solutions to improve the efficiency and acceptability of this procedure in the future.

This European scale study aims to identify and review the different legal framework and ethical recommendations elaborated in European countries to disclose genetic information to family members.

You can find further information here.

If you are a geneticist or genetic counsellor please and you would like to take part, Please complete the questionnaire (https://columbo.univ-amu.fr/index.php/589445?lang=en). It should take about 10 minutes. Your input would be very much appreciated.

Please contact Marion Gottrau if you have any questions.